Protecting the Next Generation: What Is the Role of the Duration of Human Papillomavirus Vaccine–Related Immunity?

Abstract

Optimization of the design of immunization strategies for treatment of HPV depends substantially on the duration of vaccine-induced immunity. Given the uncertainty in estimating this duration, it may be prudent to assume a value close to the lower limit reported and adjust the program when more-accurate information for the length of vaccine-induced immunity becomes available.